期刊名称:BRAIN TUMOR PATHOLOGY
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and scope
Brain Tumor Pathology is the official journal of the Japan Society of Brain Tumor Pathology. This international journal documents the latest research and topical debate in all clinical and experimental fields relating to brain tumors, especially brain tumor pathology. The journal has been published since 1983 and has been recognized worldwide as a unique journal of high quality. The journal welcomes the submission of manuscripts from any country. Membership in the society is not a prerequisite for submission. The journal publishes original articles, case reports, rapid short communications, instructional lectures, review articles, letters to the editor, and topics. The latter are papers recommended at the annual meeting of the Japan Society of Brain Tumor Pathology. All contributions should be aimed at promoting international scientific collaboration.
Instructions to Authors
Instructions for Authors
Brain Tumor Pathology


Manuscript for Publication
Manuscripts for publication and all correspondence should be sent to:  The Editorial Office of Brain Tumor Pathology Department of Neurosurgery Kansai Medical University c/o Dr. Keiji Kawamoto 10?5 Fumizonocho Moriguchi, Osaka 570 Japan Tel.:+81-6-6992-1001 Fax: +81-6-6991-6207.
Manuscript Form
Three complete sets of manuscripts, including tables and figures, must be supplied; the abstract, text, references, tables, and figure legends must be typed double-space with wide margins on one side of good-quality A4 paper. A complete list of submitted materials must accompany each manuscript. Incomplete or improperly prepared manuscripts will be returned to the authors without review. A separate title page should be provided. The abstract, text, acknowledgments, references, tables, legends, and figures should begin on separate sheets and follow in that order. Standard abbreviations and units should be used.  Abbreviations should be defined at first appearance, and their use in the title and abstract should be avoided. Generic names of drugs and chemicals should be used. All manuscripts must be written in English. Authors who are not fluent in English must seek the assistance of a colleague who is a native English speaker and is familiar with the field of the work. Manuscripts that have been extensively modified in the editorial process will be returned to the authors for retyping.
Diskettes
The submission of diskettes is encouraged, but they should not be sent until changes requested following the review process have been entered and authors have been notified of acceptance for publication. Authors are requested to follow the instructions printed in the journal for preparation of diskettes.
Manuscript Style
Title page Titles should be brief, specific, and informative. Include 
 Abstract


|
A concise description (not more than 200 words) of the purpose, methods, results, and conclusions is required. |  Text


|
The text of original articles should be divided into the following sections: introduction, materials and methods, results, discussion, and conclusion. The sections for case reports should be: introduction, clinical summary, pathological findings, and discussion. |  References Number references consecutively in the order cited in the text, not alphabetically. The accuracy of reference data is the authors?responsibility. Personal communications and unpublished data should not be included in the reference list but may be cited in parentheses in the text. If such a citation is from someone other than the authors, a letter should be submitted in which the direct quotation is given with the signature of its author.  In the reference list, provide inclusive page numbers for all references. Give the names of the first three authors only, followed by 揺t al?if there are other coauthors. Journal titles should be abbreviated according to Index Medicus. For papers written in Japanese, follow the style of example 2. References should be cited using superscript numbers, e.g., Bonin et al.,1 Tsuchie and Tochikura,2 and Dressler.3


|
1. Bonin JK, Rubinstein LJ, Papasozomenos SC, et al (1994) Subependymal giant cell astrocytoma: significance and possible cytogenic implications of an immunohistochemical study. Acta Neuropathol (Berl) 62:185?93 |


|
2. Tsuchie H, Tochikura A (1993) Anti-HIV- 1 p17 antibody as anti-HIV agent (in Japanese). Nippon Rinsho (Jpn J Clin Med) 51:213?18 |


|
3. Dressler LG (1990) Controls, standards, and histogram interpretations in DNA flow cytometry. In: Darzynkiewicz Z, Crissman HA (eds) Flow cytometry: methods in cell biology, vol 33. Academic, San Diego, pp 179?83 |
Illustration Style
Tables


|
Should be cited in the text. Each table should be given a number and a brief informative title and should appear on a separate page. Explain in footnotes all abbreviations used. |  Figures


|
Should be used with discretion and are justified only if they clarify or reduce the text required. Information given in captions should not be repeated in the text. 1A/1 Previously published illustrations usually are not accepted. |


|
Figures should be cited in the text and should be numbered sequentially with arabic numerals. A brief descriptive legend should be provided for each figure; legends are part of the text and should be appended to it on a separate page. The top of the figure, the author抯 name, and the figure number should be indicated lightly in soft pencil on the back of each figure. |


|
The figures should match the size of either the column width (8.6cm) or the printing area (17.6 x 23.6cm). Related figures should be grouped into a plate on one page (17.6 x 23.6 cm). If plates are submitted, the figure numbers should appear on the artwork, and the figures must be mounted on regular bond paper, not on cardboard. The figures, including legends, should not exceed the printing area. |


|
In micrographs, a bar should be used as a size reference, with the length of the bar indicated in the figure legend. A magnification factor given in the legend is not acceptable. |


|
Color illustrations will be accepted; however, the author will be expected to make a contribution to the extra cost (?10 000 for the first color page and ?0000 for each additional color page). In this case, original slides (35 x 24mm) must be submitted together with three prints of the slides. |  Line drawings


|
Should be good-quality glossy prints in the desired final size. The inscriptions should be clearly legible. Computer drawings are acceptable provided their quality is comparable to that of line drawings. Computer-drawn curves and lines must be smooth. Letters (capitals) 2mm high are recommended. |  Halftone illustrations
Fees and Offprints
There is no publication charge for articles not exceeding three printed pages. Three manuscript pages correspond approximately to one printed page. Illustrations and tables should also be considered. For extra pages in original articles ?5000 per extra page will be charged to the authors. Authors receive 30 complimentary offprints. Further offprints of each paper are available in lots of 50. To order these, fill out the form enclosed with the proofs.
Editorial Board
Editorial Board
Honorary Editor
Naoki Kageyama, Osaka Kintomo Takakura, Tokyo
Editor in Chief
Keiji Kawamoto, Osaka
Associate Editor
Jun Yoshida, Aichi
Editorial Board
Takumi Abe, Tokyo Norio Arita, Hyogo Nobuo Hashimoto, Kyoto Yoshio Hashizume, Aichi Takanori Hirose, Saitama Tomokatsu Hori, Tokyo Toru Iwaki, Fukuoka Nobuyuki Kawano, Kanagawa Takamasa Kayama, Yamagata Takashi Komori, Tokyo Osami Kubo, Tokyo Toshihiko Kubota, Fukui Junichi Kuratsu, Kumamoto Kaoru Kurisu, Hiroshima Makoto Kuroda, Aichi Toshihiko Kuroiwa, Osaka Takayoshi Matsui, Kagawa Akira Matsumura, Ibaraki Masao Matsutani, Saitama Yoichi Nakazato, Gunma Eisaku Ohama, Tottori Hideyuki Saya, Kumamoto Mamoru Tadokoro, Kanagawa Hitoshi Takahashi, Niigata Hideo Takeshima, Miyazaki Akira Teramoto, Tokyo Teiji Tominaga, Sendai Toshihiko Wakabayashi, Aichi Yoshihiko Yoshii, Okinawa Toshiki Yoshimine, Osaka
International Advisory Board
Mitchel S. Berger, California, USA Mark Bernstein, Toronto, Canada Peter McL, Black, Massachusetts, USA Asao Hirano, New York, USA Kurt A. Jellinger, Vienna, Austria John J. Kepes, Kansas, USA Robert L, Martuza, Massachusetts, USA Bernd W. Scheithauer, Minnesota, USA Shiguang Zhao, Harbin, China
|